Overview

Detailed Summary

Samrat Pharmachem Limited, established in 1992, primarily manufactures and sells chemicals.
A key development was the creation of a subsidiary, Samrat Remedies Limited, focusing on pharmaceutical bulk drugs and chemicals.
The company leverages its long-standing experience in chemical manufacturing to expand into pharmaceuticals, a strategic move for diversification.
Their operational strategy includes advancing their pharmaceutical segment, aiming to capture a larger market share in the industry.

Sector: Pharmaceuticals
Industry: Pharmaceuticals - Indian - Bulk Drugs
Market Cap: 63 Cr
Volatility: Low Risk
P/E Ratio: -37.5
Industry P/E: 56.7
PEG Ratio: —
P/B Ratio: 0.9
52W High: 425.00
52W Low: 195.10

Sales CAGR

1Y: 1.52%
3Y: 8.83%
5Y: 12.72%
10Y: 17.50%

Profit CAGR

1Y: 229.17%
3Y: -25.48%
5Y: 10.92%
10Y: 42.09%

ROE

TTM: 2.22%
3Y: 12.96%
5Y: 17.52%
10Y: 16.14%

ROCE

TTM: 4.92%
3Y: 18.70%
5Y: 25.33%
10Y: 24.09%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BACPHAR	50.11	72 Cr	201.01	2.68	0.00	2.42	3.29	2.78
APL	80.50	69 Cr	13.11	1.78	0.00	0.00	0.00	4.00
SAMRATPH	203.00	63 Cr	-37.45	0.89	0.49	2.22	4.92	-1.28
GODAVARI	80.10	63 Cr	16.31	1.44	0.00	12.65	11.11	2.27
SHELTER	33.20	54 Cr	5.30	0.93	0.00	13.52	17.90	12.26
VILINBIO	34.25	48 Cr	214.06	2.07	0.00	1.08	3.59	1.00
ROOPAIND	42.64	34 Cr	17.48	1.84	0.00	10.56	10.48	2.23

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	80	62	83	81	70	64	71	76	79	63
Expenses	80	62	81	78	67	59	71	76	79	64
Operating Profit	0.22	0.11	1.35	2.58	3.36	4.17	0.12	0.12	-0.36	-0.65
OPM %	0.28	0.18	1.63	3.19	4.79	6.55	0.17	0.16	-0.46	-1.02
Other Income	0.30	0.42	0.30	0.59	0.49	0.00	-0.11	0.69	0.05	0.40
Interest	0.13	0.23	0.11	0.19	0.17	0.10	0.22	0.44	0.26	0.13
Depreciation	0.16	0.16	0.16	0.16	0.17	0.17	0.16	0.17	0.18	0.19
Profit Before Tax	0.24	0.14	1.39	2.82	3.52	3.91	-0.36	0.21	-0.75	-0.57
Tax %	179.17	-142.86	-0.72	26.60	24.43	28.90	-11.11	209.52	21.33	19.30
Net Profit	-0.19	0.34	1.40	2.07	2.66	2.78	-0.40	-0.23	-0.59	-0.46
EPS in Rs	-0.61	1.11	4.52	6.68	8.61	9.01	-1.29	-0.74	-1.90	-1.49

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	77	105	125	157	204	222	311	282	286	281
Expenses	67	87	108	131	170	198	287	279	276	273
Operating Profit	9.52	18	17	26	34	24	24	2.47	10	7.77
OPM %	12.38	17.50	13.88	16.74	16.65	10.93	7.70	0.88	3.58	2.77
Other Income	0.16	0.25	0.46	0.56	0.45	0.63	0.48	1.38	0.97	NaN
Interest	0.63	0.86	1.06	0.98	1.28	0.67	1.23	0.69	0.67	0.93
Depreciation	0.43	0.41	0.42	0.43	0.49	0.59	0.64	0.65	0.65	0.67
Profit Before Tax	2.78	4.92	2.16	5.78	7.34	24	23	2.52	9.89	7.28
Tax %	36.79	34.62	28.83	26.76	27.38	27.19	26.19	14.19	28.06	33.93
Net Profit	1.75	3.22	1.54	4.24	5.33	17	17	2.16	7.11	4.81
EPS in Rs	5.69	10.41	4.98	13.70	17.26	55.63	53.83	7.00	23.01	-5.42
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	1.80	1.86	14.29	4.34	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.09	3.09	3.09	3.09	3.09	3.09	3.09	3.09	3.09	3.09
Reserves	11	12	15	17	21	27	44	60	62	69
Borrowings	5.24	6.59	8.98	6.08	9.10	8.79	7.52	19	8.45	9.91
Other Liabilities	17	14	13	14	25	19	30	35	48	40
Total Liabilities	36	36	41	40	58	57	85	117	122	121
Fixed Assets	7.28	7.01	6.99	6.86	7.19	9.40	9.99	11	11	10
CWIP	0.00	0.20	0.00	0.00	1.08	0.00	0.00	0.00	0.00	0.00
Investments	2.00	0.00	0.00	0.00	0.00	0.00	0.01	1.88	2.93	3.80
Other Assets	27	29	34	33	50	48	75	104	108	107
Total Assets	36	36	41	40	58	57	85	117	122	121

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.36	-3.23	0.13	2.37	-1.33	4.80	17	-9.44	9.41	-10
Cash from Investing Activity	-2.38	1.23	-2.44	2.18	-1.92	-2.92	-1.06	-3.00	-0.41	-0.00
Cash from Financing Activity	2.30	0.72	1.53	-3.92	2.00	-1.89	-1.95	9.60	-11	0.48
Net Cash Flow	-0.44	-1.28	-0.78	0.63	-1.25	-0.02	14	-2.84	-2.19	-9.62

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	48.64%	48.64%	48.64%	48.64%	48.64%	48.64%	48.95%	49.09%	49.09%	49.09%	49.09%	49.09%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	3.24%	3.24%	3.24%	3.66%	3.45%	3.45%	3.45%	3.24%	3.24%	3.24%	3.24%	3.24%
Public	48.13%	48.13%	48.13%	47.70%	47.91%	47.91%	47.59%	47.67%	47.67%	47.67%	47.67%	47.67%
Total Shareholders	8,039	7,938	8,445	8,065	7,478	7,169	6,984	6,844	6,785	6,752	6,699	6,488

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.